HomeNewsIndiaKarnataka government to foot bills of COVID-19 patients referred to private hospitals

Karnataka government to foot bills of COVID-19 patients referred to private hospitals

A June 23 order stated that the package rates for patients referred by the public health authorities will be Rs 5,200 for general ward, Rs 7,000 for high-dependency unit (HDU), Rs 8,500 for isolation without ventilator and Rs 10,000 for isolation with ventilator

June 25, 2020 / 12:36 IST
Story continues below Advertisement
Representative image
Representative image

The Karnataka government will bear the cost of COVID-19 treatment of patients referred by public health institutes (PHI) to private healthcare providers (PHP) in the state, reported Mint.

According to the report, the state health department has announced that it will foot the bill of referred COVID-19 patients in private hospitals after receiving criticism for fixing “high-cost treatment” at these hospitals, which are roped in to aid efforts to battle the coronavirus pandemic.

Story continues below Advertisement

“For COVID-19 patients referred by the PHIs to private healthcare providers, the cost of the treatment is completely free and (the) government will pick up the cost," stated a statement by the health department, said the report.

The government roped in private hospitals to treat COVID-19 patients in the state. It announced a cap on coronavirus treatment package rates in private hospitals for those referred by public health facilities in the range of Rs 5,200 to Rs 10,000. The rate for patients who approach private hospitals directly will be in the range of Rs 10,000 to Rs 25,000.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show